16-10930248-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000246.4(CIITA):​c.*6393C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.415 in 152,152 control chromosomes in the GnomAD database, including 14,917 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.41 ( 14910 hom., cov: 32)
Exomes 𝑓: 0.46 ( 7 hom. )

Consequence

CIITA
NM_000246.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.508

Publications

12 publications found
Variant links:
Genes affected
CIITA (HGNC:7067): (class II major histocompatibility complex transactivator) This gene encodes a protein with an acidic transcriptional activation domain, 4 LRRs (leucine-rich repeats) and a GTP binding domain. The protein is located in the nucleus and acts as a positive regulator of class II major histocompatibility complex gene transcription, and is referred to as the "master control factor" for the expression of these genes. The protein also binds GTP and uses GTP binding to facilitate its own transport into the nucleus. Once in the nucleus it does not bind DNA but rather uses an intrinsic acetyltransferase (AT) activity to act in a coactivator-like fashion. Mutations in this gene have been associated with bare lymphocyte syndrome type II (also known as hereditary MHC class II deficiency or HLA class II-deficient combined immunodeficiency), increased susceptibility to rheumatoid arthritis, multiple sclerosis, and possibly myocardial infarction. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013]
DEXI (HGNC:13267): (Dexi homolog)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.557 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CIITANM_000246.4 linkc.*6393C>T 3_prime_UTR_variant Exon 20 of 20 ENST00000324288.14 NP_000237.2
DEXINM_014015.4 linkc.*150-689G>A intron_variant Intron 1 of 1 ENST00000331808.5 NP_054734.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CIITAENST00000324288.14 linkc.*6393C>T 3_prime_UTR_variant Exon 20 of 20 1 NM_000246.4 ENSP00000316328.8
DEXIENST00000331808.5 linkc.*150-689G>A intron_variant Intron 1 of 1 1 NM_014015.4 ENSP00000330509.4

Frequencies

GnomAD3 genomes
AF:
0.415
AC:
63102
AN:
151958
Hom.:
14915
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.177
Gnomad AMI
AF:
0.470
Gnomad AMR
AF:
0.550
Gnomad ASJ
AF:
0.403
Gnomad EAS
AF:
0.574
Gnomad SAS
AF:
0.430
Gnomad FIN
AF:
0.558
Gnomad MID
AF:
0.405
Gnomad NFE
AF:
0.494
Gnomad OTH
AF:
0.444
GnomAD4 exome
AF:
0.459
AC:
34
AN:
74
Hom.:
7
Cov.:
0
AF XY:
0.423
AC XY:
22
AN XY:
52
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.833
AC:
5
AN:
6
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.611
AC:
11
AN:
18
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.400
AC:
16
AN:
40
Other (OTH)
AF:
0.250
AC:
2
AN:
8
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.530
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.415
AC:
63107
AN:
152078
Hom.:
14910
Cov.:
32
AF XY:
0.421
AC XY:
31272
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.176
AC:
7311
AN:
41498
American (AMR)
AF:
0.550
AC:
8408
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.403
AC:
1397
AN:
3470
East Asian (EAS)
AF:
0.575
AC:
2970
AN:
5168
South Asian (SAS)
AF:
0.429
AC:
2072
AN:
4826
European-Finnish (FIN)
AF:
0.558
AC:
5884
AN:
10552
Middle Eastern (MID)
AF:
0.398
AC:
117
AN:
294
European-Non Finnish (NFE)
AF:
0.494
AC:
33583
AN:
67958
Other (OTH)
AF:
0.442
AC:
936
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1747
3495
5242
6990
8737
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
584
1168
1752
2336
2920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.473
Hom.:
34114
Bravo
AF:
0.407
Asia WGS
AF:
0.502
AC:
1744
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.73
DANN
Benign
0.66
PhyloP100
-0.51
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4072865; hg19: chr16-11024105; API